Thrombotic Microangiopathy in Pregnancy: Current Understanding and Management Strategies

Kidney Int Rep. 2024 May 22;9(8):2353-2371. doi: 10.1016/j.ekir.2024.05.016. eCollection 2024 Aug.

Abstract

Thrombotic microangiopathy (TMA) represents a heterogeneous group of disorders characterized by microvascular thrombosis and end-organ damage. Pregnancy-associated thrombotic microangiopathy (p-TMA) has emerged as a distinct clinical entity with unique diagnostic challenges. Identifying the specific form of p-TMA is critical for appropriate and timely management. This review offers a comprehensive overview of the various forms of thrombotic microangiopathies associated with pregnancy, highlighting our current understanding of their pathophysiology and the evolving landscape of diagnosis and treatment for each.

Keywords: complement; microangiopathic hemolytic anemia; pregnancy; thrombocytopenia; thrombotic microangiopathy.

Publication types

  • Review